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Rodent models have been instrumental in furthering our
understanding of gastrointestinal pathophysiology. Howev-
er, there are important limitations to translating ﬁndings
from rodent models to human digestive disease, and some of
these can be overcome by large animal models.
Gastrointestinal disease is a prevalent cause of morbidity
and mortality and the use of animal models have been
instrumental in studying mechanisms of digestive patho-
physiology. As investigators attempt to translate the wealth
of basic science information developed from rodent
models, large animal models provide a number of trans-
lational advantages. The pig, in particular, is arguably one
of the most powerful models of human organ systems,
including the gastrointestinal tract. The pig has provided
important tools and insight into intestinal ischemia/
reperfusion injury, intestinal mucosal repair, as well as
new insights into esophageal injury and repair. Porcine
model development has taken advantage of the size of the
animal, allowing increased surgical and endoscopic access.
In addition, cellular tools such as the intestinal porcine
epithelial cell (IPEC-J2) line and porcine enteroids are
providing the methodology to translate basic science
ﬁndings using in-depth mechanistic analyses. Further op-
portunities in porcine digestive disease modeling include
developing additional transgenic pig strains. Collectively,
porcine models hold great promise for the future of
clinically relevant digestive disease research. (Cell Mol
Gastroenterol Hepatol 2016;2:716–724; http://dx.doi.org/
10.1016/j.jcmgh.2016.09.003)
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70 million Americans experience gastrointestinal illness
each year.1 Because of the limitations of studying human
gastrointestinal disease in a clinical environment, the use of
animal models to examine the mechanisms of gastrointes-
tinal disease has been of great importance. Rodent models
remain the most commonly used animal model for the study
of human disease because of their relatively low cost and
maintenance requirements, rapid reproduction rates, andavailability of research tools such as murine antibodies.2,3
Transgenic and knockout mice, as well as chemically
induced neoplastic and inﬂammatory disease models in
mice, have provided a tremendous amount of information
on the underlying mechanisms of clinical diseases.4,5 How-
ever, rodent models frequently fail to fully mimic clinical
signs and signiﬁcant pathologic hallmarks of human dis-
eases.6,7 Because of this, there has been recent increased
interest within the scientiﬁc community in developing large
animal models that more closely approximate the clinical
and pathologic features of human disease.8,9 Of the large
animal species used for translational research, the pig offers
a marked advantage because this species has important
anatomic and physiological similarities with human beings,
particularly in regard to the gastrointestinal tract.10,11 This
review summarizes and evaluates the current uses of large
animal models in gastrointestinal research with a particular
emphasis on porcine models.
What Is a Large Animal Model and
What Are the Advantages?
In general, any nonrodent mammalian animal species
used for translational research is considered a large animal
model. Although rodent models have been invaluable in
furthering the mechanistic understanding of human disease,
there are circumstances in which choosing a large animal
species in place of a rodent model for gastrointestinal work
is scientiﬁcally justiﬁable. For instance, when investigating
gastric disease, the dog, pig, and monkey all have a
glandular-type stomach similar to that of human beings,
whereas the murine stomach has both glandular and non-
glandular regions and therefore may have differences in
gastric pathophysiology (Figure 1).11 Of the large animal
species used in translational gastrointestinal research, the
dog has been used most extensively because canine
gastrointestinal anatomy and physiology are considered to
be highly similar to that of human beings, and dogs show
Figure 1. Schematic dia-
gram for comparison of
murine, porcine, and hu-
man gastrointestinal tract
anatomy and histology.
Derived from Nguyen TLA,
et al. How informative is
the mouse for human
gut microbiota research?
Disease Models and
Mechanisms 2015;8:
1–16. http://dx.doi.org/10.
1242/dmm.017400. Used
under Creative Commons
(https://creativecommons.
org/licenses/by/4.0/). Modi-
ﬁed with permission.
November 2016 Large Animal Models 717spontaneous naturally occurring diseases in common with
human beings, particularly neoplasia.12 However, dogs are
highly sensitive to some disease models, particularly intes-
tinal ischemia, and experience high rates of mortality.13 In
addition, there is growing social aversion to the use of the
dog as a laboratory animal.14 Calves have been established
as a model for human enteric infectious disease, particularlySalmonellosis. Cattle may become naturally infected with
Salmonella enterica serotype typhimurium and they show a
disease state very analogous to human salmonellosis.
Therefore, the calf commonly is used to study Salmonella
species infection and the host–pathogen interaction, trans-
lating ﬁndings to human disease as well as to veterinary
medicine and agriculture.15 This recently was called Dual
Table 1.Porcine Digestive Disease Models Available
Disease or syndrome modeled References
Esophageal metaplasia and neoplasia 24,38
Stress-induced intestinal dysfunction 75–81
Intestinal ischemia/reperfusion injury and repair 13,14,50,54,61,82–87
Necrotizing enterocolitis 40,41,88–91
Short-bowel syndrome 92,93
Intestinal transplantation 67
Colorectal cancer 94
Cystic ﬁbrosis 73,74,95–97
Diabetes mellitus 98,99
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National Institutes of Health (http://grants.nih.gov/grants/
guide/pa-ﬁles/PAR-16-366.html). However, the application
of ruminant models for the study of other human gastro-
intestinal biology is limited owing to the fundamental dif-
ference in digestive anatomy and physiology. Alternatively,
the pig is becoming progressively appreciated as a distinctly
advantageous model for human beings in numerous ﬁelds of
science, and an increasing number of textbooks, articles, and
proceedings are being published that outline pig models in
biomedical research, including digestive disease research
(Table 1).16 The pig has many fundamental anatomic,
physiological, genomic, proteomic, immunologic, and nutri-
tional similarities to human beings.12,16–22 The pig also
shows potential for interspecies transplantation work, as
well as the ability to fulﬁll United States Food and Drug
Administration requirements for pharmaceutical testing.23
These features of the pig combined with an increasing
availability of biological tools and reagents for use to study
porcine tissue make the pig arguably the best model avail-
able for translational biomedical research.
Despite the numerous advantages of large animal
models, several key limitations have impeded their wide-
spread use in biomedical research in favor of rodent models.
The most signiﬁcant limitation to large animal models is the
increased cost of animal maintenance and husbandry. Large
animal species require larger, more specialized housing and
surgical facilities, with higher expenses related to feed,
veterinary care, and surgery costs. In addition, their longer
reproductive cycles and growth rates make large animal
work slower and more expensive. This has hampered the
development of transgenic animals.Characterization of the Porcine
Gastrointestinal Tract
There are many notable similarities between the human
and porcine gastrointestinal tracts, which make the porcine
model a powerful tool for studying gastrointestinal disease.
For example, the esophagus is very similar to that of human
beings in that both species have esophageal submucosal
glands as do human beings, whereas rodents do not.24 The
stomach of the pig is entirely glandular, making it physio-
logically comparable with that of human beings.11 Thestructure of the small intestine is comparable in human
beings and pigs, and the intestinal length (meters) per
bodyweight (kilograms) ratio is approximately 0.1 in both
species, compared with approximately 0.16 in mice.10,25,26
The epithelial cell population (cell lineages, phenotypes,
and expression of distinct protein biomarkers) of the
porcine small intestine is similar to that of human beings.27
The villus structure is ﬁnger-like in pigs, mice, and human
beings, whereas rats have a leaf-like villus structure.28 The
subcellular structure of porcine enterocytes within the crypt
base have been characterized and found to be similar to the
description of these cells in human beings.23,29 The colon of
the pig and human beings both possess sacculations and
longitudinal muscular bands (tenia) along their length,
which results in similar transit times and thus comparable
digestive physiology in the intestine, whereas the colon of
the mouse and rat are nonsacculated.30,31 Pigs and human
beings are capable of fermenting digesta within the colon,
and have been shown to have similar microbial ﬂora within
the small intestine and large intestine.32,33 Conversely, the
microbiota of the mouse and human are signiﬁcantly
divergent, with approximately 85% of mouse gut microbiota
being absent from human ﬂora.34 Nonetheless, there are
important differences in the pig as compared with human
beings, including the absence of an appendix, a much larger
and more developed cecum, and the spiral arrangement of
the colon in the pig (Figure 1).11,16
Examples of Large Animal Models
in Digestive Disease
Esophageal Disease
The dog and pig have been used extensively to study
esophageal disease, with similarities in disease pathophys-
iology more similar to human beings than that of ro-
dents.35,36 For instance, in a chronic model of acid reﬂux
disease, the dog develops a phenotype of esophageal
adenocarcinoma that is similar to the glandular phenotype
seen in human beings as opposed to the mucinous pheno-
type of mice and rats.37 In pigs, the esophageal and
gastroesophageal junctional anatomy and physiology are
comparable with that of human beings, both sharing the
existence of large, dissectible submucosal glands, making
the pig a preferred model for analogous clinical applica-
tions.11,24,38 In particular, pigs are used commonly to test
new surgical and endoscopic techniques in the esophagus.
Recently, a pig model of esophageal injury and repair was
developed in which endoscopic radiofrequency ablation was
used to induce injury, followed by the study of cellular
biology of the repair process, including the location and role
of proliferative cells.24 This model promises to provide
important information on the role of key structures such as
esophageal submucosal glands in the repair process.
Necrotizing Enterocolitis
Neonatal mouse models of necrotizing enterocolitis
(NEC) have been of limited utility in studies of the disease
because of high mortality related to cesarean section rather
than to the development of NEC.39 Alternatively, piglets
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human infant formula diet spontaneously develop NEC
within 30 hours of birth in approximately 50% of in-
dividuals, providing a powerful tool to investigate the
development of this complex multifactorial disease pro-
cess.40,41 The piglet is the only animal model described to
develop full-scale, clinical NEC in response to the same risk
factors correlated to human NEC: prematurity, enteral for-
mula feeding, and unintended bacterial colonization of the
intestine.40,41 The severity of NEC in affected models has
made it difﬁcult to use this model repeatedly to produce
translational ﬁndings, and this work is expensive because of
the labor required to maintain NEC model piglets. None-
theless, the piglet model provides substantial opportunities
for further investigation of this devastating disease.Intestinal Ischemia/Reperfusion Injury
The study of intestinal ischemia/reperfusion injury has
been studied in several large animal species. A low-ﬂow
ischemic model, as would be seen in hemorrhagic or car-
diovascular shock, has been studied extensively and char-
acterized in cats using an adjustable vascular clamp.42,43
Segmental mesenteric ischemia, as noted in volvulus or
trauma, has been induced in the pig, dog, and cat, as well as
the horse.44–47 In each of these models, the choice of animal
species has a substantial impact on the pathology and
clinical outcome.48 For instance, the porcine small intestinal
tract has low levels of the key oxidant-generating enzyme
xanthine oxidase, which has been shown to be largely
responsible for reperfusion injury in feline and rodent
models that have relatively high levels of intestinal xanthine
oxidase. Similar to pigs, human beings have low levels of
xanthine oxidase, particularly in neonates, as is the case in
piglets. This lack of xanthine oxidase has been associated
with a minor role of reperfusion injury after segmental
ischemia in the pig, and we believe that this is likely the case
in the human small intestinal tract.49
Repair and Regeneration of Injured
Intestine: Insights From Porcine Studies
One consequence of discovering a minor role of reper-
fusion injury in porcine small intestinal ischemia was an
increased focus on intestinal reparative events.50 Although
mucosal epithelial restitution has been studied in an in vitro
guinea pig ileum detergent-injury model, many factors have
contributed to the feasibility and superiority of the
ischemia/reperfusion pig model for the study of the intes-
tinal epithelial barrier.51 In particular, similar intestinal
ischemia/reperfusion models in mice result in devitalization
of the mucosal tissue in the ex vivo Ussing chamber system,
whereas the pig mucosa survives well, allowing intensive
study of reparative events.52,53 The relatively large body
size of pigs allows access to long lengths of intestine that
can be separated readily into multiple distinct segments for
the study of differing periods of ischemia/reperfusion,
or the development of more complex models such as
Thierry–Vella loops.49 The latter have proved particularlyuseful for determining the effect of luminal factors on
mucosal repair in the conscious animal.54,55Early Events in Mucosal Repair
During surgically induced segmental mesenteric
ischemia in the small intestine, the epithelium lifts from the
basement membrane and sloughs from the villous tips in a
time-dependent and highly predictable manner, after which
there is a rapid and reproducible early recovery process
that occurs before epithelial proliferation: (1) villus
contraction, (2) epithelial migration, and (3) tight junction
closure (Figure 2).49
Villus contraction. First, individual villi contract, effec-
tively reducing the surface area of denuded basement
membrane.56 This process is facilitated by a network of
smooth muscle cells and contractile myoﬁbroblasts orga-
nized in a 3-dimensional reticular network within the lam-
ina propria.56,57 Enteric nerves mediate the initial
contraction immediately after mucosal injury, whereas the
continued contraction is dependent on the production of
prostaglandins within the affected tissue.56,58
Epithelial migration. The second critical step is the
depolarization and mobilization of wound-associated
epithelial cells that remain in the mucosa after injury, a
process termed restitution. This migratory phenotype in the
wound-associated epithelial cells begins with a de-
differentiation and ﬂattening of the cell (loss of polarity
and enterocyte microstructures) and extension of plasma
membrane (lamellipodia) in the direction of restitution
coinciding with detachment of the trailing edge to facilitate
crawling across the denuded basement membrane.51,59,60
This process is facilitated by the remodeling of the actin-
myosin cytoskeleton to extend and contract the cell
plasma membrane; the disassembly, transport, and reas-
sembly of focal adhesion complexes from the trailing edge to
the leading edge of the crawling cell; and effective adhesion
of transmembrane integrins within these focal adhesions to
the extracellular matrix.44
Tight junction restoration. The ﬁnal and arguably the
most critical phase of early barrier repair is resealing of the
tight junctions. Once the wound-associated epithelial cells
have covered the exposed basement membrane and make
cell-to-cell contact over the injured villus tip, tight junctions
reassemble at the apical paracellular space and the epithe-
lial barrier is functionally repaired. This process has been
studied principally in the porcine ischemia/reperfusion
model using ex vivo recovery studies in Ussing chambers,
allowing for the measurement of transepithelial electrical
resistance and macromolecular ﬂuxes in recovering
tissues.61 This work has established a direct correlation
between increasing transepithelial electrical resistance,
reduction of macromolecular permeability, and recovery of
barrier function that is in very large part dependent on the
reassembly of tight junctions.62 In other words, although
restitution of epithelium is vital for mucosal wound repair,
barrier function is not restored until tight junctions are
re-assembled. This latter step has been relatively underap-
preciated in digestive disease research, but emphasized by
Figure 2. Illustration showing the phases of intestinal epithelial barrier repair. Restoration of barrier function after damage to
the epithelium is well characterized to occur in 3 phases. (1) Contraction of villus occurs by smooth muscle ﬁbroblasts in the
lamina propria to reduce denuded surface area. (2) Depolarization and migration of wound-associated epithelial cells occurs
across the denuded basement membrane to cover the wounded surface. (3) Repolarization and reformation of tight junction
structure to seal the paracellular spaces occurs, effectively restoring barrier function. (A) Transmission electron microscopy
showing open paracellular space between 2 intestinal epithelial cells with a leaky tight junction (white arrows). (B) TEM showing
closed paracellular space and tight junction (white arrows) coinciding with restoration of intestinal barrier function. Panels A
and B were used with permission from Little D, et al. PI3K signaling is required for prostaglandin-induced mucosal recovery in
ischemia-injured porcine ileum. Am J Physiol Gastrointest Liver Physiol 2003;284:G46–G56.
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the recovery of barrier function in human beings with a
variety of conditions in which the mucosa is injured. As an
example of the translational signiﬁcance of the pig model,
tight junction repair has been linked principally to the
chloride channel chloride channel 2, and chloride channel 2
agonists presently on the market have been shown to hasten
mucosal repair via tight junction modulation in preclinical
porcine trials.47Inﬂammatory Events
Early reparative events continue unimpeded by inﬂam-
mation during ex vivo studies in which tissues are not
reperfused. However, the role of inﬂammation in mucosal
injury and repair is very important. Other large animal
models, particularly studies in the cat, have highlighted the
important role of neutrophil-driven reperfusion injury, set
off by initial oxidant production by xanthine oxidase.43 As
previously mentioned, human and porcine intestine have
relatively low expression of xanthine oxidase, with a near-
complete absence of reperfusion injury in porcine models
of ischemia, hemorrhagic shock, volvulus, and segmental
ischemia.49,63,64 However, there is an impressive neutro-
philic inﬁltration in postischemic porcine intestine that
becomes maximal between 6 and 12 hours in vivo in tissues
injured by 2 hours of complete intestinal ischemia. This is
essentially the inﬂammatory phase of wound healing, as
would be expected for dermal wounds. Interestingly,
although inﬁltration of neutrophils likely is critical for
destroying invading microorganisms, neutrophils damage
the recently repaired epithelial barrier as they migratethrough the paracellular spaces and physically disrupt tight
junctions.63 Porcine studies have shown that blockade of
neutrophilic oxidants during the reparative stages of
mucosal wound repair can maintain the barrier established
by early reparative events.63 Thus, although inﬂammatory
events have been studied extensively in rodent models, the
focus on early reperfusion injury in rodent models rather
than the role of inﬂammation during repair, as has been
studied to a limited extent in porcine ischemia, has perhaps
hampered the translation of anti-inﬂammatory therapy such
as blockade of neutrophil adhesion or function to the level
of clinical trials.65 Therefore, the pig may provide ﬁndings
that can be translated more readily.Mucosal Proliferative Response
In the subacute period after ischemia/reperfusion, there
is an impressive proliferative response from the stem cell
niche within the crypts, followed by re-establishment of
normal villus structure.49,66 The latter has been modulated
by luminal factors (glutamine and transforming growth
factor a) in a Thierry–Vella loop model of porcine ischemic
injury.55 In more recent work, the cell lineages that are
present along the crypt-villus axis of both pigs and human
beings have been shown to have similar morphology and
unique biomarkers.27 Importantly, the intestinal crypt base
columnar cells of the pig have been characterized morpho-
logically and found to be similar in appearance to human
crypt base columnar cells.27 As a model of the stem cell
niche, porcine enteroid culture recently was developed,
allowing the expansion of epithelial progenitors together
with their identiﬁcation.27 Optimum culture methods to
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weeks have been established, and transplantation of intes-
tinal crypts into the omentum of pigs has resulted in the
growth of histologically complete intestine including villi,
crypts, lamina propria, nerve elements, and muscularis
mucosa.27,67,68 Methods for cryopreservation and genetic
manipulation of porcine enteroids also have been successful,
further establishing the porcine enteroid model as a
powerful tool for intestinal studies and preclinical
assessment.68
Large Animal Cell Culture Models
of Intestinal Physiology
To augment the porcine in vivo study of intestinal dis-
ease, a novel intestinal epithelial cell line (IPEC-J2) was
isolated and cultured from neonatal pig jejunum in 1989 by
Helen Berschneider at North Carolina State University that
has many unique characteristics. For example, these cells
are nontransformed yet have been maintained through 80
to 90 passages. Furthermore, they are derived from the
small intestine, unlike frequently used cell lines derived
from colonic tissue such as Caco-2, HT-29, and T84 cells,
and they consist of a heterogeneous population of cell
phenotypes, mimicking the epithelial diversity seen in vivo.
IPEC-J2 cells form a fully differentiated columnar epithelial
monolayer with an established brush border, tight junction
structure, inducible chloride secretion, and a functional
barrier as measured by transepithelial electrical resistance
and macromolecular ﬂuxes.69,70 These qualities make this
cell line a powerful tool for the study of intestinal biology
and disease in the pig that, in turn, means they likely have
important translational applications given the similarities
between human and porcine intestinal cell populations.27
This cell line has since been used successfully to study
key elements of intestinal cell biology, particularly for
immunologic and microbiological studies.71 These cells are
grown easily on permeable membranes and can be placed in
Ussing chambers for advanced barrier physiology studies.69
In addition, the IPEC-J2 line has been transfected success-
fully by plasmid vector to stably overexpress select targets
such as human P-glycoprotein (ABCB1), further supporting
this cell line as a powerful tool for the translatable study of
small intestinal epithelial biology and disease.72
Future Needs for Large Animal Models
and Research Tools
The major limitation of work on large animal models of
digestive disease remains the relative lack of genetic
models. There are important examples of porcine genetic
models of human disease, notably the cystic ﬁbrosis trans-
membrane conductance regulator (CFTR) knockout pig.
Genetically induced cystic ﬁbrosis mouse models do not
develop key pathologies in the lung and pancreas seen in
human cystic ﬁbrosis, leading Rogers et al73 to produce a
CFTRþ/- pig to generate a more clinically analogous model of
cystic ﬁbrosis to that of human beings. The following gen-
erations of CFTR knockout pigs showed cystic ﬁbrosis–likelung disease and severe pancreatic dysfunction within the
ﬁrst few months of life, making this model an important
translational model for the study of cystic ﬁbrosis in human
beings.74 Although availability of reagents optimized for use
in porcine studies lags behind availability for human and
murine applications, the market is improving and at the
time of this review, a search on the CiteAb database (Bath,
United Kingdom) showed in excess of 87,000 antiporcine
antibodies cited to perform in biological research applica-
tions in pigs. However, additional reagents to identify
cellular targets as well as genetic models of disease are
needed to further translational work. For example, in the
porcine small intestinal stem cell niche, it is not pres-
ently possible to identify leucine-rich repeat-containing
G-protein–coupled–receptor protein positive crypt-based
columnar cells because of a lack of reliable antibodies for
this protein marker. In addition, the lack of identiﬁable
Paneth cells in the stem cell niche, based on historically
used biomarkers or morphologic features, has presented an
interesting dilemma as well as an opportunity to under-
stand the stem cell niche. Speciﬁcally, there must be a cell
type that supports crypt base columnar cells in the porcine
small intestine, as is the case in the colon in pig and human
being, where there are no Paneth cells.
Conclusions
Continued work to understand gastrointestinal patho-
physiology in the pig using a variety of clinically relevant
surgical, interventional, genetic, and cellular models will
shed light on the translational signiﬁcance of recent
important basic science ﬁndings.References
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